Oslo / Coventry / Helsinki / Oxford / Neuroreport / Arlington / /
Company
Gould / LG / Recip / Siemens Medical Systems / Charles Wolfson Charitable Trust / Ford / Meda AB / Alzheimer’s Research Trust / Shimizu / John Coates Charitable Trust / Elizabeth Corob Charitable Trust / /
Country
Sweden / Norway / United States / United Kingdom / / /
Event
FDA Phase / /
Facility
Washington University / Montreal Neurological Institute / National Institute / University of Oxford / University of Warwick / Institute of Basic Medical Sciences / Warneford Hospital / FMRIB Software Library / John Radcliffe Hospital / University of Oslo / Weir DG / /
IndustryTerm
volumetric magnetic resonance imaging / default mode network / connectivity networks / preprocessed structural imaging / imaging / visuospatial processing / prevention of Alzheimer’s disease / clinical functional magnetic resonance imaging research studies / /
John Radcliffe Hospital / Harvard / Montreal Neurological Institute / Washington University in St. Louis / St. Louis / Medical Research Council / University of Oxford / National Institute for Health Research / Artificial Intelligence / Nuffield Department of Clinical Neurosciences / Association for Uncertainty / Warneford Hospital / Institute of Basic Medical Sciences / University of Oslo / University of Warwick / National Health Service / Henry Smith Charity / /
Person
Arch Neurol / Thomas E. Nicholsa / Helga Refsumb / Rita Marasco / Ann Neurol / Stephen M. Smitha / A. David Smithb / Robin Jacobye / Joe Ramsey / Celeste A. de Jagerc / /
Position
C.A.d.J. / linear non-Gaussian acyclic model for causal discovery / atrophy Author / /
Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment Gwenaëlle Douauda,b,1, Helga Refsumb,c,d, Celeste A. de Jagerc, Robin Jacobye, Thomas E. Nicholsa,f,g, Stephen M. Smitha, and A. David